LQDA
LQDA
NASDAQ · Pharmaceuticals

Liquidia Corp

$42.30
+0.02 (+0.05%)
As of May 10, 9:56 PM ET ·
Financial Highlights (FY 2026)
Revenue
162.03M
Net Income
-70,537,483
Gross Margin
91.6%
Profit Margin
-43.5%
Rev Growth
+115.0%
D/E Ratio
1.49
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 91.6% 58.0% 52.5% 52.5%
Operating Margin -32.4% -807.4% 26.8% 26.1%
Profit Margin -43.5% -885.1% 19.2% 19.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 162.03M 12.24M 783.80M 707.55M
Gross Profit 148.48M 7.10M 411.26M 371.25M
Operating Income -52,577,917 -98,848,235 210.20M 184.67M
Net Income -70,537,483 -102,665,771 150.56M 137.41M
Gross Margin 91.6% 58.0% 52.5% 52.5%
Operating Margin -32.4% -807.4% 26.8% 26.1%
Profit Margin -43.5% -885.1% 19.2% 19.4%
Rev Growth +115.0% +2.9% +0.6% +0.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.12B 913.17M 962.93M 1.24B
Total Equity 747.04M 611.43M 1.27B 1.28B
D/E Ratio 1.49 1.49 0.76 0.97
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -52,553,023 -104,281,125 266.89M 249.48M
Free Cash Flow 76.52M 82.10M